Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 54, pseudogene (RNU6-54P) is a non-protein-coding pseudogene of the U6 small nuclear RNA gene family[1][8]. As a pseudogene, it does not encode a functional product and, specifically, it is classified as a small nuclear RNA (snRNA) pseudogene, which are generally relics of once-functional genes that have lost their protein-coding ability or biological function through evolution[1][8][4]. U6 snRNA itself is a core component of the spliceosome, involved in pre-mRNA splicing, but pseudogenes such as RNU6-54P do not contribute functional snRNA to this process[1][8][9]. Although some pseudogenes may have regulatory roles, such as acting as decoys for microRNAs or sources of regulatory RNAs, there is currently no evidence that RNU6-54P is a therapeutic target or that it has direct clinical or pathological relevance[4]. Present knowledge considers RNU6-54P a genomic marker with no established protein-coding or direct regulatory function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 54, pseudogene (RNU6-54P).